Effects of Dietary Nitrate in Hypertensive Pregnant Women
- Conditions
- PregnancyHypertension
- Interventions
- Dietary Supplement: Beetroot juiceDietary Supplement: Nitrate-depleted beetroot juice
- Registration Number
- NCT02520687
- Lead Sponsor
- University of Manchester
- Brief Summary
High blood pressure in pregnancy affects around 10% of pregnancies, and is associated with serious adverse outcomes for both mother and baby. Treatment options for the management of high blood pressure in pregnancy are currently limited. Studies in non-pregnant individuals have shown that supplementation with dietary nitrate, using beetroot juice, can significantly lower blood pressure and improve blood flow. This study aims to investigate whether supplementation with dietary nitrate (via beetroot juice) can improve blood pressure regulation in pregnant women with chronic high blood pressure, and will also determine whether this can improve blood flow across the placenta.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 44
- Women diagnosed with chronic hypertension (systolic blood pressure of 130-144 mmHg and/or diastolic blood pressure of 80-94 mmHg).
- Between 22 - 35+6 weeks gestation
- Multi-fetal pregnancy
- Currently taking anti-hypertensive medication
- Pre-existing diabetes (Type 1 or Type 2)
- Lacking ability to consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Dietary nitrate, beetroot juice Beetroot juice Once daily 70mL dose of beetroot juice, containing 400mg inorganic nitrate, for 7 consecutive days. Nitrate-depleted beetroot juice Nitrate-depleted beetroot juice Once daily 70mL dose of beetroot juice, depleted of nitrate, for 7 consecutive days.
- Primary Outcome Measures
Name Time Method Change in clinic blood pressure (compared to baseline) between treatment and placebo groups The outcome will be determined after 7 days treatment (compared to baseline)
- Secondary Outcome Measures
Name Time Method Recruitment rates Across study (18 months) Uterine artery blood flow (compared to baseline) The outcome will be determined after 7 days treatment (compared to baseline) Umbilical artery blood flow (compared to baseline) The outcome will be determined after 7 days treatment (compared to baseline) Changes in plasma and salivary nitrate concentrations The outcome will be determined after 7 days treatment (compared to baseline) Changes in plasma and salivary nitrite concentrations The outcome will be determined after 7 days treatment (compared to baseline)
Trial Locations
- Locations (1)
Maternal and Fetal Health Research Centre
🇬🇧Manchester, United Kingdom